» Articles » PMID: 11978521

The Role of Pathologists in the Quality Control of Diagnosis and Treatment of Rectal Cancer-an Overview

Overview
Journal Eur J Cancer
Specialty Oncology
Date 2002 Apr 30
PMID 11978521
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Pathological examination of the rectal cancer resection specimen has an increasingly important role in influencing decisions about clinical management. Standardisation of the examination procedures and reporting are necessary. To evaluate the relevant pathological factors, data from randomised clinical trials with adequate follow-up are necessary. From a recently closed trial on the treatment of rectal cancer (preoperative radiotherapy or total mesorectal excision (TME) surgery alone?), the pathological data were used to evaluate the importance of pathological factors, like circumferential margin and tumour, lymph nodes, metastasis (TNM) stage. Furthermore, it was possible to evaluate the surgical procedures and correlate these findings to clinically relevant endpoints. In this review, we describe the standard evaluation of a rectal cancer specimen with special attention to preoperative irradiated specimens.

Citing Articles

Preoperative Radiotherapy with a Simultaneous Integrated Boost Compared to Chemoradiotherapy for cT3-4 Rectal Cancer: Long-Term Results of a Multicenter Randomized Study.

Engels B, De Paoli A, Delmastro E, Munoz F, Vagge S, Norkus D Cancers (Basel). 2023; 15(15).

PMID: 37568685 PMC: 10416952. DOI: 10.3390/cancers15153869.


Supine bottom-up extralevator abdominoperineal excision for anorectal adenocarcinoma is not inferior to standard approach and may be thus safely performed.

Mege D, de Chaisemartin C, Regis-Marigny L, Poizat F, Meillat H, Zemmour C Surg Endosc. 2023; 37(7):5226-5235.

PMID: 36952048 DOI: 10.1007/s00464-021-08982-1.


The Multidisciplinary Approach of Rectal Cancer: The Experience of "COMRE Group" Model.

Scabini S, Romairone E, Pertile D, Massobrio A, Aprile A, Tagliafico L Diagnostics (Basel). 2022; 12(7).

PMID: 35885477 PMC: 9319737. DOI: 10.3390/diagnostics12071571.


Update on Robotic Total Mesorectal Excision for Rectal Cancer.

Giuratrabocchetta S, Formisano G, Salaj A, Opocher E, Ferraro L, Toti F J Pers Med. 2021; 11(9).

PMID: 34575677 PMC: 8472541. DOI: 10.3390/jpm11090900.


Association of visual and quantitative heterogeneity of 18F-FDG PET images with treatment response in locally advanced rectal cancer: A feasibility study.

Martin-Gonzalez P, de Mariscal E, Martino M, Gordaliza P, Peligros I, Carreras J PLoS One. 2020; 15(11):e0242597.

PMID: 33253194 PMC: 7704000. DOI: 10.1371/journal.pone.0242597.